Introduction: Microbial fermentation of carbohydrates in forestomach of ruminants produces large amounts of short-chain fatty acids (SCFA, mainly acetic acid, propionic acid, and n-butyric acid). The majority of these substrates is taken up directly across the ruminal wall. After luminal uptake into the epithelial cells, SCFA mainly occur in the dissociated form due to the intracellular pH of ~7.4. Moreover, a big portion of SCFA is metabolised within the cytosol. Main end products of epithelial SCFA metabolism are ketone bodies (D-3-hydroxybutyric acid and acetoacetic acid) and lactic acid. Both intact SCFA and ketone bodies and lactate need to be efficiently extruded from the ruminal epithelial cells to prevent a lethal drop of intracellular pH and counteract osmotic load of the cytosol. All these substances are less lipophilic in comparison to the undissociated form of SCFA. Thus, dissociated SCFA (SCFA-) and their metabolites need Protein mediated mechanisms for the extrusion across the basolateral side of ruminal epithelium. One mechanism suggested to be involved in the extrusion of SCFA- across basolateral membrane of the ruminal epithelium is the monocarboxylate transporter 1 (MCT1). Functionally, MCT1 was first assumed to operate as proton-coupled transporter for monocarboxylates including SCFA. Nonetheless, a recent study found a bicarbonate dependent anion exchange mechanism which turned out to be sensitive to MCT1 Inhibitors at the basolateral side of the ruminal epithelium pointing to the ability of MCT1 to act as an anion exchanger. However, in these experiments the inhibition of MCT1 abolished bicarbonate dependent transport only by half. This suggests the involvement of further anion exchanger(s) in the transport of SCFA across the basolateral membrane of ruminal epithelium. Promising candidates to underlie this exchange are the putative Anion exchanger 1 (PAT1) and a transport protein designated „down-regulated in adenoma“ (DRA). Materials and Methods: Sheep rumen epithelium was mounted in Ussing Chambers under short-circuit conditions. Radioactively labelled acetate (ac) was added to the serosal side. Serosal to mucosal flux of ac (Jsm ac) was measured with or without anion Exchange inhibitors (50 mM NO3- or 1 mM DIDS) or the MCT1 inhibitor p-hydroxy mercuribenzoic acid (pHMB; 1.5 mM) in the serosal buffer solution. The inhibitors were added alone or in combination with each other. Furthermore, mucosal to serosal flux of radioactivelly labelled ac or butyrate (bu) (Jms ac, bu) was measured in the presence or absence of SO42-, Cl- or NO3- (50 mM respectively) as exchange substrate in the serosal buffer solution. Immunohistochemical staining was conducted to locate PAT1 and DRA by use of commercially available antibodies. Results: NO3- and pHMB significantly reduced Jsm ac by 57 % and 51 %, respectively. When pHMB was applied after pre-incubation with NO3- an additional inhibition of Jsm ac was observed. Vice versa, NO3- further inhibited Jsm ac when epithelia were pre-incubated with pHMB before. DIDS had no inhibitory effect on SCFA flux. Serosal presence of SO42- or Cl- enhanced Jms ac significantly. Regarding bu, Cl- or SO4 2- also enhanced Jms bu significantly. The different anions available in the serosal buffer solution numerically enhanced Jms in the order of SO4 2- > Cl- for both ac and bu, which corresponds to the known affinity sequence of PAT1 and DRA. Immunohistochemistry revealed localization of PAT 1 in the stratum basale, whereas DRA was not detectable using this method. Conclusions: Basically, this study supports the suggestion that MCT1 works as an Anion exchanger in ruminal epithelium. In addition, it clearly shows that there is at least one further anion exchanger involved in the basolateral extrusion of SCFA and their metabolites. The functional and immunohistochemical findings suggest that PAT1 holds a significant role in this respect.:1 Introduction 1 2 Literature Review 3 2.1 Importance of short-chain fatty acid production of ruminants 3 2.2 Apical uptake of short-chain fatty acids from the rumen 5 2.2.1 Apical uptake of undissociated SCFA from the rumen 6 2.2.2 Apical uptake of dissociated fatty acids from the rumen 8 2.3 Intraepithelial metabolism of short-chain fatty acids 9 2.4 Mechanisms for the basolateral discharge of the short-chain fatty acids 11 2.4.1 Basolateral extrusion of short-chain fatty acids in other gastrointestinal tract epithelia 12 2.4.2 Basolateral extrusion of short-chain fatty acids in ruminal epithelium 14 2.4.3 Further candidate proteins for extrusion of SCFA- in exchange for HCO3 - 19 2.4.3.1 Putative Anion transporter 1 (PAT1 = SLC26A6) 19 2.4.3.2 Down-regulated in adenoma (DRA = SLC26A3) 21 2.4.3.3 Anion exchanger 2 (AE2 = SLC4A2) 22 2.5 Literature implications for this study 23 3 Materials and Methods 24 3.1 Animals 24 3.2 Ussing chamber studies 24 3.2.1 Buffer solutions 24 3.2.2 Preparation of ruminal epithelium 25 3.2.3 Incubation 25 3.2.4 Electrophysiological parameters 26 3.3 Experimental procedure 27 3.3.1 Determination of the unidirectional SCFA flux rate 29 3.4 Experimental Setups 30 3.4.1 Sensitivity of Jsm ac to inhibitors 30 3.4.1.1 Effect of nitrate and pHMB on Jsm ac 30 3.4.1.2 Effect of DIDS, NO3 - and pHMB on Jsm ac 31 3.4.2 Effect of the basolateral replacement of the anions on the extrusion of SCFA 32 3.4.2.1 Effect of Cl- and NO3 - on Jms of acetate and butyrate 32 3.4.2.2 Effect of SO4 2- on Jms of acetate and butyrate 32 3.4.3 Effect of different anions available in the serosal solution on Jms of acetate and butyrate 33 3.5 Immunohistochemistry 34 3.5.1 Preparation of the samples. 34 3.5.2 Fixation and staining of the samples. 34 3.5.3 Evaluation 35 3.6 Statistical analysis 36 4 Results 37 4.1 Inhibitors sensitivity 37 4.1.1 Effect of nitrate and pHMB on Jsm ac 37 4.1.2 Effect of DIDS, pHMB and NO3 - on Jsm ac 41 4.2 Effect of Cl- and NO3 - on Jms of acetate and butyrate 43 4.2.1 Effect of SO4 2- on Jms of acetate and butyrate 44 4.3 Effect of Cl-, NO3 - or SO4 2- when present in the serosal solution for 150 min 49 4.4 Immunohistochemistry 52 5 Discussion 54 5.1Ussing chamber experiments 56 5.1.1 Effect of Cl- and NO3 - on Jms of acetate 56 5.1.2 Effect of nitrate and pHMB on Jsm of acetate 57 5.1.3 Effect of DIDS, pHMB or NO3 - on Jsm of acetat 58 5.1.4 Effect of SO4 2- on Jms of acetate 59 5.1.5 Comparison between different anions as exchange substrate for the basolateral extrusion of acetate 60 5.2 Immunohistochemistry 62 5.3 Comparison between basolateral extrusion of butyrate and acetate 62 5.4 Conclusions 64 6 Summary 66 7 Zusammenfassung 68 8 References 70 Ac Aknowledgements

Increases in basolateral amygdala (BLA) activity drive avoidance-seeking behavior that may be associated with stress induced drug seeking. Activity of BLA pyramidal neurons is regulated by local and paracapsular gamma aminobutyric acid (GABA) interneurons. The lateral paracapsular interneurons (LPCs) border the external capsule, receive dense cortical/thalamic input and provide feed-forward inhibition onto BLA principle neurons. The GABAergic LPCs also express high concentrations of g-protein coupled µ-opioid receptors (MORs). Therefore, the effects of opiates on LPC activity and local GABA release were examined. Fluorescently double labeled LPCs were observed in glutamate decarboxylase (GAD) 65-mcherry/GAD67-green fluorescent protein (GFP) transgenic mice. Whole-cell electrophysiology experiments demonstrated that acute exposure to [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO; a synthetic selective MOR agonist), reduced LPC firing and spontaneous inhibitory postsynaptic current (sIPSC) frequency in LPCs, with no apparent effect on spontaneous excitatory currents (sEPSCs). Current injection induced firing in LPC neurons, but less effectively than in saline controls. Morphine-exposed mice (10mg/kg/day, across 5 days, 1-2 days off) had increased sIPSCs compared to saline-injected controls, as well as enhanced adenylyl cyclase (AC) activity. Together these data show that LPC neurons are a highly sensitive targets for opiate-induced inhibition, and that long-term opiate exposure results in impaired LPC excitability, possibly contributing to anxiety observed during opiate withdrawal.

Indiana University-Purdue University Indianapolis (IUPUI) / Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder that affects roughly 1 in 3500 individuals. In addition to physical features (e.g., neurofibromas), developmental disorders are also common that can affect cognition, learning, attention and social function. The NF1 gene encodes neurofibromin, a GTPase activating protein (GAP)-like protein that negatively regulates Ras GTPase activation. Mutation at the NF1 locus increases the output of MAPK and PI3K signal transduction from the cellular membrane to the nucleus. Similar to humans, Nf1+/- mice show spatial learning abnormalities that are potentially correlated with increases in GABA-mediated inhibition and deficits in long-term potentiation in the hippocampus. Here, we demonstrate for the first time that Nf1+/- mice exhibit a selective loss of long-term social learning / memory and increased GABAergic inhibition in the basolateral amygdala, a critical brain region for regulating social behaviors. Next, utilizing a genetic intercross, we show that the co-deletion of p21-activated kinase type 1 (Pak1-/-), which positively regulates MAPK activation, restores Nf1+/--dependent MAPK hyperactivation in neurons cultured from the frontal cortex. We found that the co-deletion of Pak1 in Nf1+/- mice (Nf1+/- / Pak1-/-) also restores the deficits in long-term social learning / memory seen in Nf1+/- mice and normalizes the increases in GABA-mediated inhibition in the BLA, as compared to Nf1+/- mice. Together, these findings establish a role for Nf1 and Pak1 genes in the regulation of social learning in Nf1-deficient mice. Furthermore, proteomic studies identify dysregulation of F-actin and microtubule dynamics in the prefrontal cortex, and implicate proteins associated with vesicular release as well as neurite formation and outgrowth (e.g., LSAMP, STXBP1, DREB). In the BLA, disintegrin and metalloproteinase domain-containing protein 22 (ADAM22) was identified, and ADAM22 may play a role in the regulation of AMPA receptors. Finally, due to the increased co-occurrence of NF1 and autism, these findings may also have important implications for the pathology and treatment of NF1-related social deficits and some forms of autism.

Bien que la neurotransmission glutamatergique joue un rôle pivot dans le développement et l’expression de la sensibilisation comportementale aux amphétamines, le rôle spécifique de certaines structures glutamatergiques qui projettent sur l’aire tegmentale ventrale et/ou le noyau accumbens n’est pas encore bien caractérisé. Nous montrons que l’hippocampe dorsal, la partie prélimbique du cortex préfrontal et l’amygdale basolatérale joue un rôle prépondérant dans les réponses locomotrices induites par l’administration aiguë (développement de la sensibilisation) et chronique (expression de la sensibilisation) d’amphétamines, suggérant les réponses locomotrices aux amphétamines impliquent un ensemble de structures glutamatergiques corticolimbiques. Par la suite, nous nous sommes intéressés au rôle de la neurotransmission glutamatergique associée aux récepteurs NMDA dans le noyau accumbens, qui est considéré comme le noyau clé de l’expression de la sensibilisation, sur le développement à court terme de la sensibilisation aux amphétamines. De plus, nous montrons le développement de la sensibilisation à court terme aux amphétamines requiert l’activation concomitante de certains récepteurs NMDA au glutamate et nicotiniques à l’acétylcholine dans le noyau accumbens. De plus, l’activation concomitante de ces récepteurs sous tend également la libération de dopamine induite par les amphétamines dans le noyau accumbens. L’ensemble de ces données montre que la neurotransmission glutamatergique, et les structures glutamatergiques qui projettent sur l’aire tegmentale ventrale et/ou le noyau accumbens, joue un rôle majeur dans la sensibilisation comportementale à court terme aux amphétamines. / Although it is well admitted that the glutamatergic neurotransmission plays a pivotal role in the development and expression of behavioral sensitization to amphetamine, the specific role of glutamatergic structures that project to the ventral tegmental and/or the nucleus accumbens is less well studied. We showed that the dorsal hippocampus, the prelimbic part of the prefrontal cortex and the basolateral amygdala play a critical role in both acute (development of sensitization) and chronic (expression of sensitization) locomotor responses induced by amphetamine, suggesting that behavioral responses to amphetamine are mediated by circuitry of corticolimbic glutamatergic structures. Next, we investigated the role of glutamatergic NMDA receptors contained in the nucleus accumbens, which is seen as the key structure for the expression of sensitization, in the development of short term sensitization to amphetamine. Interestingly, we showed that, contrasting with the current dichotomous thinking that has attributed specialized functions to the ventral tegmental area and the nucleus accumbens, respectively in the development and the expression of behavioral sensitization, concomitant activation of certain types of NMDA and nicotinic receptors in the nucleus accumbens is also required for the development of short term sensitization. Furthermore, we showed that concomitant activation of these receptors sustained the amphetamine-induced dopamine release in the nucleus accumbens. All these data show that glutamatergic neurotransmission, and glutamatergic structures which project onto mésoaccumbens system, plays a major role in short-term behavioral sensitization to amphetamine.

La maladie de Parkinson est caractérisée par la manifestation de symptômes moteursprincipalement dus à la dégénérescence du système dopaminergique. Malgré l'accent mis surles déficits moteurs, la maladie de Parkinson est également caractérisée par des symptômesnon moteurs, incluant l'anxiété et la dépression, qui sont sous-étudiés et de ce fait pas bientraités. Alors que certaines études cliniques ont suggéré que l'anxiété et la dépressionpourraient être associées à la dégénérescence des neurones dopaminergiques, d'autres ontsuggéré l'implication de la dégénérescence des neurones noradrénergiques etsérotoninergiques dans les troubles observés mais également dans les effets induits par laLévodopa et la stimulation cérébrale profonde du noyau sous-thalamique.Dans un premier temps, nous avons étudié le rôle respectif de la dopamine, de lanoradrénaline et de la sérotonine dans la manifestation des déficits parkinsoniens moteurs etnon moteurs chez le rat. L’ensemble de nos résultats démontre que malgré l’importance dusystème dopaminergique, la perturbation des trois systèmes monoaminergiques joue un rôleimportant à la fois dans la manifestation des troubles moteurs et non moteurs.Nous avons également étudier l’impact des monoamines sur l’efficacité des traitementsantiparkinsoniens, à savoir, la Lévodopa et la stimulation cérébrale profonde du noyau sousthalamique,sur les troubles observés. Nos résultats montrent que la déplétion combinée dessystèmes monoaminergiques peut altérer l’efficacité de la Lévodopa ainsi que de lastimulation cérébrale profonde sur certains troubles. Ces résultats peuvent expliquer lemanque d’efficacité des traitements antiparkinsoniens chez certains patients et la difficulté àtraiter tous les symptômes.Pour finir, nous avons voulu mettre en évidence le lien entre le noyau sous-thalamique,structure excitatrice des ganglions de la base et les troubles moteurs, ainsi que l’amygdalebasolatérale et l’habénula latérale, structures impliquées dans les comportements émotionnels,et les troubles non moteurs. Nous avons mis en évidence le parallèle existant entre lesmodifications du mode de décharge des neurones du NST et les troubles moteurs, leschangements de l’amygdale basolatérale et les troubles anxieux ainsi que ceux de l’habénulalatérale et les troubles dépressifs.Les résultats de ces travaux de thèse ont donc permis d’apporter de nouvelles évidences surl’implication des trois systèmes monoaminergiques dans la physiopathologie et la thérapie dela maladie de Parkinson. / Parkinson’s disease is characterized by the manifestation of motor symptoms mostlyassociated with the degeneration of dopaminergic neurons. While Parkinson’s disease is oftenfocused on motor deficits, the disease is also characterized by non-motor deficits, includinganxiety and depression, which are under studied and consequently are not well treated.Whereas some clinical studies suggested that anxiety and depression could be linked to thedegeneration of dopaminergic neurons, others suggested the involvement of norepinephrineand serotonin in the observed symptoms and also in the efficacy of Levodopa and deep brainstimulation of the subthalamic nucleus.In a first time, we investigated the respective role of the neuronal degeneration of dopamine,noradrenaline and serotonin in the manifestation of motor and non-motor parkinsonian-likedisorders in the rat. Our results demonstrate that despite the importance of the dopaminergicsystem, the disturbances in the three-monoaminergic systems play a key role in themanifestation of motor and non-motor deficits.In a second time, we studied the impact of monoamine depletions on the efficacy ofantiparkinsonian treatments, the Levodopa and deep brain stimulation of the subthalamicnucleus. Our results showed that the combined depletions could deteriorate the efficacy of theLevodopa and of the deep brain stimulation on some deficits. Together, these results canexplain the lack of efficacy of the antiparkinsonian treatments in some patients and thedifficulty to treat all the symptoms.Finally, we investigated the link between the subthalamic nucleus, which is an excitatorystructure of the basal ganglia, and the motor deficits, as well as the involvement of thebasolateral amygdala and the lateral habenula in emotional control of the behavior, and nonmotordeficits. We showed the parallel between changes in the neuronal activity of thesubthalamic nucleus and the motor deficits, of the basolateral amygdala and anxiety and ofthe lateral habenula and depression.Results from this thesis provide new evidences on the involvement of the threemonoaminergicsystems in the pathophysiology and the therapy of Parkinson’s disease.

Les stimuli conditionnés (CS) guident les animaux vers des récompenses essentielles à leur survie, telle que la quête de nourriture et d'eau. Ils peuvent également promouvoir la poursuite excessive de récompense, comme dans l’addiction. La transmission glutamatergique dans l’amygdale basolatérale (BLA) régule les effets des CS. Cependant, le rôle des récepteurs glutamatergiques métabotropes du groupe II (mGlu2/3) de la BLA est inconnu. Les mGlu2/3 sont principalement localisés au niveau extrasynaptique sur les terminaisons neuronales. L’activation de ces récepteurs diminue la libération synaptique de glutamate. Ainsi, nous avons émis l’hypothèse que l'activation des mGlu2/3 dans la BLA diminue la capacité des CS à potentialiser la recherche de récompense via la réduction de la libération de glutamate. La méthode de transfert Pavlovien-à-instrumental (PIT) a été utilisée pour tester cette hypothèse. Nous avons d'abord confirmé un effet PIT chez des rats mâles. Les rats ont initialement appris à appuyer sur un levier pour obtenir de l’eau comme récompense. Ils ont ensuite appris qu'un stimulus auditif (CS+) prédit la livraison non-contingente d'eau, tandis qu’un stimulus auditif différent (CS-) ne signale aucune récompense. Le jour du test PIT, les rats ont pu appuyer sur le levier sous extinction (eau omise) et nous avons évalué l’influence des CS+ et CS- sur ce comportement. Les rats ont appuyé davantage sur le levier pendant le CS+ comparé au CS-, indiquant que le CS+ incite les rats à rechercher la récompense. Chez un nouveau groupe de rats mâles, les mêmes méthodes ont été appliquées avec un agoniste des mGlu2/3, le LY379268 (0, 3 ou 6 μg/hémisphère) injecté dans la BLA avant le test PIT. Le LY379268 a diminué la capacité du CS+ à inciter l’appui sur le levier. Dans une dernière étude, nous avons examiné l’influence d’une administration systémique de LY379268 (0, 0.3 ou 1 mg/kg, sous-cutanée) sur l’effet PIT chez un groupe de rats mâles et femelles. Les effets motivationnels du CS+ sur la recherche de récompense étaient similaires entre les rats mâles et femelles. De plus, l’injection systémique de LY379268 a diminué ces effets chez les deux sexes. Ces résultats indiquent que les mGlu2/3 régulent les propriétés motivationnelles des CS chez les deux sexes. / Conditioned stimuli (CS) guide animals towards rewards needed for survival, such as food and water. In parallel, they can also promote maladaptive reward seeking, as in addiction. Glutamate signaling within the basolateral amygdala (BLA) modulates the effects of cues. However, the role of metabotropic group II glutamate (mGlu2/3) receptors in the BLA is unknown. mGlu2/3 are localized predominantly extrasynaptically on presynaptic terminals. The activation of these receptors suppresses synaptic glutamate release. Thus, we hypothesized that activating BLA mGlu2/3 receptors would attenuate cue-triggered increases in incentive motivation for reward, via reduced glutamate release. The Pavlovian-to-Instrumental transfer (PIT) method was used to test this hypothesis. We first confirmed a PIT effect in a cohort of male rats. Rats initially learned to press a lever to obtain a water reward. Then, they learned that one auditory cue predicts noncontingent delivery of water (CS+), while a second different auditory cue does not (CS-). On PIT test day, the rats could lever press under extinction (water deliveries omitted), and we assessed changes in lever pressing in response to CS+ and CS-. The rats pressed more on the lever during CS+ versus CS-, indicating cue-triggered potentiation of incentive motivation. In a separate cohort of male rats, the methods were repeated with the mGlu2/3 agonist LY379268 (0, 3 or 6 μg/hemisphere) infused into the BLA prior to PIT testing. LY379268 abolished CS+ potentiated pressing on the water-associated lever. In a last study, we examined the influence of systemic administration of LY379268 (0, 0.3 or 1 mg/kg, subcutaneous) on PIT, in a cohort of female and male rats. We found that cue-triggered increases in incentive motivation was similar across sexes, and that systemic injection of LY379268 decreased this effect in both sexes. These results indicate that mGlu2/3 receptors mediate the motivational effects of cues in both sexes.

很多行為的建構基礎是來自酬賞動機，而個體的行為表現通常是動態的歷程，其中對酬賞物的“價值”比較，是決定行為是否輸出或輸出多少的重要關鍵。在鼠類的動物行為模式中，可以利用甜液舔飲來進行這種對比(contrast)歷程的實驗。在受試可先後獲得兩次舔飲機會的實驗情境中，若兩管濃度皆為4%的蔗糖液先後間隔特定時距出現，受試會隨訓練天數增加而增加對兩管糖液的舔飲表現。若第一管4%蔗糖液之後會呈現濃度較高的32%蔗糖液，受試舔飲第一管同為濃度4%蔗糖液的表現會隨訓練天數增加而先增後減。這兩組受試對第一管糖液的舔飲量差異，即稱為預期性對比效果。一般認為此現象是受試等待與預期較高酬賞價值的糖液，而抑制當前較低酬賞價值糖液的舔飲。過去對此現象的研究主要關注在行為層面的探討，然而其相關神經機制的研究並不多，本研究的目的即在於探討與習得或形成預期性對比行為有關的神經機制。一般認為預期性對比效果的習得包含多階段的歷程，可能與多種心理行為面向有關，因此很有可能是經由多元性的神經機制參與。預期性對比效果的形成與否與兩糖液呈現的間距長短有很大的關係。本研究實驗一以0.5分鐘、2分鐘以及6分鐘三個不同的糖液間距引發的預期對比效果，從當中選取可有效形成預期性對比效果的0.5分鐘為實驗二糖液間距的依據。實驗二分別以興奮性神經毒素破壞依核核心區、眶前額皮質區以及杏仁體基側核區等三個神經區域。結果顯示杏仁核基側核區破壞不影響預期性對比效果的習得，而依核核心區以及眶前額皮質的破壞使受試無法習得預期性對比效果。綜合以上結果，預期性對比效果的習得是依靠有效的糖液呈現間距去進行酬賞比較，腦中依核核心區及眶前額皮質區與該種對比有關。 / Many types of behavior are constructed on the basis of reward motivation, which can be run in dynamic processes. Among those processes potentially involved, the reward comparison is a key determinant for the magnitude of behavioral output. The licking of sweet solution in the rat can be used as an animal model to investigate the contrast effect derived from reward comparison. In which, the subjects presented two sweet solutions in a sequential order each day may suppress intake of the first solution if the second solution is preferred. This phenomenon is termed anticipatory contrast effect (ACE). It is hypothesized that ACE could be built via an inhibition process associated with subject’s waiting for a preferred solution as presented by a less preferred solution. Most of the previous studies were mainly focused on the behavioral aspects of ACE. The present study intended to investigate the neural mechanisms of ACE. In considering that the formation of ACE requires multiple-stage processes, this study presumed that more than one brain area could be involved in mediating those psycho-behavioral processes. Experiment 1 was intended to establish behavioral model by manipulating the effectiveness of different inter-solution interval (ISI; 0.5, 2.0, and 6.0 min). The results showed that the ISI of 0.5 min is the critical parameters for the successful formation of ACE, which was then applied in Experiment 2. Experiment 2 investigated the effects of excitotoxin lesion conducted by ibotenic acid in the nucleus accumbens core (NACc), orbitofrontal cortex (OFC) or basolateral amygdala (BLA) on the acquisition of ACE. The result showed the rats with NACc or OFC lesion significantly failed to acquire ACE, but no such impairment appeared to BLA lesion. Together, these data suggest that the formation of ACE is depended upon the ISI leading to an effective reward comparison, and the NACc or OFC is involved in such a contrast processing.

Ciliary neurotrophic factor (CNTF) is produced by astrocytes which have been implicated in regulating stress responses. We found that CNTF in the medial amygdala (MeA) promotes despair or passive coping, i.e., immobility in an acute forced swim stress, in female mice, while having no effect in males. Neutralizing CNTF antibody injected into the MeA of wildtype females reduced activation of downstream STAT3 (Y705) 24 and 48 h later. In concert, the antibody reduced immobility in the swim test in females and only after MeA injection, but not when injected in the central or basolateral amygdala. Antibody injected into the male MeA did not affect immobility. These data reveal a unique role of CNTF in female MeA in promoting despair or passive coping behavior. Moreover, 4 weeks of chronic unpredictable stress (CUS) increased immobility in the swim test and reduced sucrose preference in wildtype CNTF+/+, but not CNTF-/- littermate, females. Following CUS, 10 min of restraint stress increased plasma corticosterone levels only in CNTF+/+ females. In males, the CUS effects were present in both genotypes. Further, CUS increased CNTF expression in the MeA of female, but not male, mice. CUS did not alter CNTF in the female hippocampus, hypothalamus and bed nucleus of stria terminalis. This suggests that MeA CNTF has a female-specific role in promoting CUS-induced despair or passive coping, behavioral anhedonia and neuroendocrine responses. Compared to CNTF+/+ mice, CNTF-/- mice did not show differences in CUS-induced anxiety-like behavior and sensorimotor gating function as measured by elevated T-Maze, open field and pre-pulse inhibition of the acoustic startle response. Together, this study reveals a novel CNTF-mediated female-specific mechanism in stress responses and points to opportunities for developing treatments for stress-related disorders in women.